Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion type Assertion NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_head.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion evidence source_evidence_literature NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion SIO_000772 19752219 NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion wasDerivedFrom befree-20140225 NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.
- NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_assertion wasGeneratedBy ECO_0000203 NP182718.RAdEBBESqB5kkPyStmxVSQsMu9P6b4Eno9XHxD4h7XV-s130_provenance.